Metformin Side Effects: A Complete Guide

Gastrointestinal symptoms are by far the most frequently reported side effects of metformin and are the main reason some patients struggle with adherence in the early weeks of treatment.

Clinical trial data show that up to 25% of patients starting standard-release metformin experience some degree of GI disturbance.

Diarrhoea

This is the single most common side effect, affecting approximately 15 to 20% of patients during the first month. The diarrhoea is typically watery, non-bloody and most pronounced after meals.

It occurs because metformin increases intestinal motility and alters bile salt absorption.

Nausea and vomiting

Up to 10% of patients report nausea, usually in the first 1 to 2 weeks. Taking metformin with or immediately after food significantly reduces this symptom.

Vomiting is less common and often settles within a few days.

Abdominal cramps and bloating

Crampy lower abdominal pain and a sensation of fullness or bloating are reported by around 5 to 10% of users.

These symptoms are related to changes in gut motility and fermentation of unabsorbed carbohydrates in the colon.

Metallic taste

A metallic or bitter taste in the mouth (dysgeusia) affects roughly 3% of patients. This is an unusual but well-recognised side effect that can affect appetite and food enjoyment.

The good news is that GI side effects almost always improve over 4 to 6 weeks as the body adapts.

Gradual dose titration, starting at 500 mg once daily and increasing by 500 mg each week, is the standard approach recommended by the BNF and substantially reduces the severity of these symptoms.

Long-term metformin use is associated with reduced vitamin B12 absorption, an effect that is increasingly recognised as clinically significant.

The mechanism involves metformin interfering with the calcium-dependent uptake of the intrinsic factor-B12 complex in the terminal ileum.

How common is it?

Studies estimate that 5 to 30% of patients taking metformin for more than 4 years develop low vitamin B12 levels. The risk increases with higher doses and longer duration of treatment.

A landmark randomised controlled trial (the HOME study) found that metformin 850 mg three times daily reduced mean B12 levels by 19% over 4.3 years compared with placebo.

Symptoms to watch for

• Fatigue and generalised weakness
• Peripheral neuropathy: tingling, numbness or burning in the hands and feet
• Cognitive changes: poor concentration, memory difficulties
• Macrocytic anaemia: detected on a full blood count as a raised mean cell volume (MCV)
• Glossitis: a sore, smooth tongue

The challenge is that B12-related peripheral neuropathy can mimic or worsen diabetic neuropathy, making it easy to attribute symptoms to diabetes alone and miss the treatable B12 deficiency.

Monitoring and treatment

NICE and the BNF recommend checking vitamin B12 levels periodically in patients on long-term metformin, particularly if symptoms of neuropathy develop.

If levels are low, supplementation with oral cyanocobalamin (1 mg daily) or intramuscular hydroxocobalamin injections is effective.

Early detection and treatment can reverse neurological symptoms before they become permanent.

Lactic acidosis is the most feared complication of metformin therapy, though it is extremely rare.

The estimated incidence is approximately 3 to 10 cases per 100,000 patient-years, which equates to roughly 1 in 30,000 patients per year.

What is lactic acidosis?

It is a metabolic emergency in which lactic acid builds up in the bloodstream faster than it can be cleared, causing the blood to become dangerously acidic.

Metformin can contribute to this by inhibiting hepatic gluconeogenesis and, at toxic concentrations, impairing mitochondrial function.

Who is at risk?

Lactic acidosis with metformin almost never occurs in patients with normal kidney and liver function at standard doses.

• Acute kidney injury or severe chronic kidney disease (eGFR below 30 mL/min)
• Acute decompensated heart failure with tissue hypoperfusion
• Severe dehydration (for example, from vomiting, diarrhoea or inadequate fluid intake during illness)
• Hepatic failure
• Excessive alcohol consumption
• Sepsis or any condition causing tissue hypoxia

Symptoms

Early symptoms are non-specific and include nausea, vomiting, abdominal pain, muscle cramps, fatigue and rapid breathing.

As acidosis worsens, confusion, drowsiness and cardiovascular collapse can occur.

What to do

If you feel significantly unwell while taking metformin, particularly during an intercurrent illness, stop taking it and seek medical advice promptly.

The BNF advises temporarily suspending metformin during periods of acute illness, dehydration or before procedures involving iodinated contrast media.

Several evidence-based strategies can help you tolerate metformin better, particularly during the initial weeks when GI side effects are most troublesome.

Gradual dose titration

The BNF recommends starting at 500 mg once daily with a meal, then increasing by 500 mg every 1 to 2 weeks up to the target dose (usually 1,000 mg to 2,000 mg daily).

This slow approach gives the gut time to adapt and reduces the intensity of diarrhoea and nausea by up to 50% compared with starting at the full dose.

Take it with food

Swallowing metformin in the middle of or immediately after a meal buffers its local effect on the stomach and slows absorption.

This is the single most effective lifestyle measure for reducing GI symptoms.

Switch to modified-release (MR) tablets

Metformin MR (also called slow-release or prolonged-release) delivers the drug more gradually, which significantly reduces GI side effects.

A meta-analysis found that MR formulations cut the incidence of diarrhoea by approximately 50% compared with standard-release.

If you are struggling with GI symptoms on immediate-release tablets, ask your prescriber about switching.

Avoid trigger foods

High-sugar and high-fat meals can worsen metformin-related diarrhoea. Reducing refined carbohydrates and eating regular, balanced meals helps stabilise gut function.

Stay hydrated

Diarrhoea and nausea can lead to dehydration, which in turn increases the risk of kidney strain and lactic acidosis. Aim for at least 1.

5 to 2 litres of water per day, more in warm weather or during illness.

Monitor your B12

Ask your doctor to check your vitamin B12 level at least once a year if you have been on metformin for more than 12 months. Early detection of deficiency prevents irreversible neurological damage.

Beyond the well-known GI effects, metformin has a small number of less common side effects that are worth being aware of.

Skin reactions

Rash, itching and erythema are reported in fewer than 1% of patients. These are usually mild and resolve on discontinuation. True allergic reactions to metformin are very rare.

Hepatic effects

Isolated cases of abnormal liver function tests have been reported, though metformin is generally considered safe for the liver.

In fact, emerging evidence suggests metformin may have a protective effect against non-alcoholic fatty liver disease (NAFLD), a condition common in patients with type 2 diabetes.

Reduced appetite and weight changes

Metformin is weight-neutral to mildly weight-reducing, which is considered a benefit rather than a side effect for most patients with type 2 diabetes.

However, some patients experience a more pronounced appetite suppression that leads to insufficient calorie intake. If you are losing weight unintentionally, discuss this with your diabetes team.

Hypoglycaemia

When used alone, metformin very rarely causes hypoglycaemia because it does not stimulate insulin secretion.

However, when combined with sulphonylureas (such as gliclazide) or insulin, the risk of low blood sugar increases.

Patients on combination therapy should be educated about recognising and treating hypoglycaemia.

Impact on kidney function

Metformin itself does not damage the kidneys. However, it is cleared by the kidneys, so impaired renal function leads to accumulation.

The BNF provides clear eGFR thresholds: reduce the dose if eGFR falls to 30 to 45 mL/min and stop metformin if eGFR drops below 30 mL/min.

Most metformin side effects are manageable, but certain symptoms warrant a prompt conversation with your healthcare team or urgent medical attention.

Speak to your GP or diabetes nurse if:

• GI symptoms (diarrhoea, nausea, cramping) have not improved after 4 to 6 weeks of gradual dose titration
• You notice tingling, numbness or burning in your hands or feet that is new or worsening
• You are losing weight without trying
• You feel unusually tired or weak despite adequate sleep and nutrition
• Your blood glucose readings are consistently outside your target range

Seek urgent medical attention if:

• You develop severe vomiting or diarrhoea that prevents you from keeping fluids down
• You experience rapid or laboured breathing with muscle cramps and confusion
• You feel profoundly unwell during an intercurrent illness (infection, fever, dehydration)
• You notice signs of a severe allergic reaction: facial swelling, hives or difficulty breathing

Sick-day rules

If you are unwell with vomiting, diarrhoea or a high fever, temporarily stop metformin and contact your GP. This is sometimes called the sick-day rule for metformin.

Dehydration and acute kidney injury during illness can cause metformin to accumulate to dangerous levels.

Resume your normal dose only when you are eating and drinking normally again and feeling better.

Keep your diabetes team's contact details accessible so you can reach them quickly if you are concerned about any aspect of your treatment.